Document is current
Any future updates will be listed below
-
Authors
Visioli, Alberto
Trivieri, Nadia
Mencarelli, Gandino
Giani, Fabrizio
Copetti, Massimiliano
Palumbo, Orazio
Pracella, Riccardo
Cariglia, Maria Grazia
Barile, Chiara
Mischitelli, Luigi
Soriano, Amata Amy
Palumbo, Pietro
Legnani, Federico
DiMeco, Francesco
Gorgoglione, Leonardo
Pesole, Graziano
Vescovi, Angelo L.
Binda, Elena http://orcid.org/0000-0002-8750-2905
-
Funding
Funding for this research was provided by:
Ministero della Salute (GR-2011-02351534, Progetto Ricerca Corrente 2018-20, Progetto Ricerca Corrente 2020-2023)
Associazione Italiana per la Ricerca sul Cancro (IG-22027)
- License Information
-
More Information
Article History
Received: 7 June 2023
Accepted: 26 August 2023
First Online: 21 September 2023
Declarations
:
: The cohort of glioma patients analyzed in this study was enrolled at IRCCS National Neurologic Institute “C. Besta” after approval of the institutional Ethic board number protocol n°02 and protocol n°61. All the subject with a confirmed diagnosis of GBM agreed to participate according to the ethical guidelines of the 2013 Declaration of Helsinki with signed informed consent. Material was anonymized at the time of collection. All animal procedures were performed according to the Guidelines for the Care and Use of Laboratory Animals and experimental protocols approved by the Italian Ministry of Health (805/2016-PR and 119/2019-PR).
: All authors approved the manuscript and consent publication.
: The authors declare no competing interests. AL Vescovi has ownership interest in Hyperstem SA.
